Literature DB >> 14991689

De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.

B A Budnik1, J V Olsen, T A Egorov, V E Anisimova, T G Galkina, A K Musolyamov, E V Grishin, R A Zubarev.   

Abstract

Antimicrobial peptides (AMPs), named lycocitin 1, 2 and 3, and a peptide with a monoisotopic molecular mass of 3038.70 Da were detected in the venom glands of the wolf spider Lycosa singoriensis. Two of the peptides, lycocitin 1 and 2, are new AMPs whereas lycocitin 3 is highly homologous to lycotoxin II isolated from the venom of spider Lycosa carolinensis. In addition, two other peptides with monoisotopic masses of 2034.20 and 2340.28 Da showing the motif typical for antimicrobial peptides were also identified. These peptides and lycocitin 1, 2 and 3 were de novo sequenced using electron capture dissociation and low-energy collisional tandem mass spectrometry. The amino acid sequence of lycocitin 1 was determined as GKLQAFLAKMKEIAAQTL-NH(2). Lycocitin 2 differs from lycocitin 1 by a replacement of a lysine residue for an arginine residue at the second position. Lycocitin 3 differs from the known lycotoxin II consisting of 27 amino acid residues by a deletion of Gly-26. Both lycocitin 1 and 2 inhibit growth of Gram-positive (Staphylococcus aureus, Bacillus subtilis) and Gram-negative (Escherichia coli) bacteria and fungi (Candida albicans, Pseudomonas aeruginosa) at micromolar concentrations. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991689     DOI: 10.1002/jms.577

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  13 in total

1.  A venom-derived neurotoxin, CsTx-1, from the spider Cupiennius salei exhibits cytolytic activities.

Authors:  Lucia Kuhn-Nentwig; Irina M Fedorova; Benjamin P Lüscher; Lukas S Kopp; Christian Trachsel; Johann Schaller; Xuan Lan Vu; Thomas Seebeck; Kathrin Streitberger; Wolfgang Nentwig; Erwin Sigel; Lev G Magazanik
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

2.  Insights into Antimicrobial Peptides from Spiders and Scorpions.

Authors:  Xiuqing Wang; Guangshun Wang
Journal:  Protein Pept Lett       Date:  2016       Impact factor: 1.890

Review 3.  Fourier transform mass spectrometry.

Authors:  Michaela Scigelova; Martin Hornshaw; Anastassios Giannakopulos; Alexander Makarov
Journal:  Mol Cell Proteomics       Date:  2011-07       Impact factor: 5.911

Review 4.  Anticancer, antimicrobial, and analgesic activities of spider venoms.

Authors:  Hassan M Akef
Journal:  Toxicol Res (Camb)       Date:  2018-03-08       Impact factor: 3.524

5.  Analysis of tandem mass spectra by FTMS for improved large-scale proteomics with superior protein quantification.

Authors:  Graeme C McAlister; Doug Phanstiel; Craig D Wenger; M Violet Lee; Joshua J Coon
Journal:  Anal Chem       Date:  2010-01-01       Impact factor: 6.986

6.  Rondonin an antifungal peptide from spider (Acanthoscurria rondoniae) haemolymph.

Authors:  K C T Riciluca; R S R Sayegh; R L Melo; P I Silva
Journal:  Results Immunol       Date:  2012-04-02

7.  In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei.

Authors:  R Perumal Samy; A Pachiappan; P Gopalakrishnakone; Maung M Thwin; Yap E Hian; Vincent T K Chow; Ho Bow; Joseph T Weng
Journal:  BMC Infect Dis       Date:  2006-06-20       Impact factor: 3.090

8.  In vitro antibacterial effect of wasp (Vespa orientalis) venom.

Authors:  Jafar Jalaei; Mehdi Fazeli; Hamid Rajaian; Seyed Shahram Shekarforoush
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-05-20

9.  Linear Peptides-A Combinatorial Innovation in the Venom of Some Modern Spiders.

Authors:  Lucia Kuhn-Nentwig; Heidi E L Lischer; Stano Pekár; Nicolas Langenegger; Maria J Albo; Marco Isaia; Wolfgang Nentwig
Journal:  Front Mol Biosci       Date:  2021-07-06

10.  Cell-penetrating recombinant peptides for potential use in agricultural pest control applications.

Authors:  Stephen R Hughes; Patrick F Dowd; Eric T Johnson
Journal:  Pharmaceuticals (Basel)       Date:  2012-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.